Finally, age-related and data-driven plasma NfL concentration cutoffs were derived to indicate neurodegeneration and these were tested to predict the prevalence of abnormal NfL in neurodegenerative disorders, Down syndrome, depression, and CU individuals. This evidence concerns the gene NEFL and depressive symptom measurement.